-
M333528-1gMethyl-2-bromo-4-bromomethylbenzoate.
-
M333528-5gMethyl-2-bromo-4-bromomethylbenzoate.
-
M334143-1gMethyl-3-N-acetylamino phthalate.
-
M350534-25mgMethyl-8-(5-Hexyl-2-furyl)-octanoate.
-
M339130-10mgMethyl-D-erythritol Phosphate Disodium Salt.
-
M331834-10mgMethyl-d3 3-Oxobutanoate.
-
M329360-100mgMicafungin is a semi-synthetic cyclic lipopeptide belonging to the echinocandin class. Unlike other marketed semi-synthetic derivatives in this class, micafungin is not derived from echinocandin but rather from FR901379, which contains a phenolic
-
M329360-10mgMicafungin is a semi-synthetic cyclic lipopeptide belonging to the echinocandin class. Unlike other marketed semi-synthetic derivatives in this class, micafungin is not derived from echinocandin but rather from FR901379, which contains a phenolic
-
M329360-25mgMicafungin is a semi-synthetic cyclic lipopeptide belonging to the echinocandin class. Unlike other marketed semi-synthetic derivatives in this class, micafungin is not derived from echinocandin but rather from FR901379, which contains a phenolic
-
M329360-50mgMicafungin is a semi-synthetic cyclic lipopeptide belonging to the echinocandin class. Unlike other marketed semi-synthetic derivatives in this class, micafungin is not derived from echinocandin but rather from FR901379, which contains a phenolic
-
M329360-5mgMicafungin is a semi-synthetic cyclic lipopeptide belonging to the echinocandin class. Unlike other marketed semi-synthetic derivatives in this class, micafungin is not derived from echinocandin but rather from FR901379, which contains a phenolic
-
M121725-10mgCytoprotective PGE1 analog that prevents NSAID-induced gastric ulceration. PGE1 analog prodrug which is rapidly de-esterified to active misoprostolic acid". Cited for extremely wide-ranging therapeutic effects, including prevention of NSAID-induced"